Boston Sci introduces smallest, thinnest high-energy CRT-Ds and ICDs

Boston Scientific announced Friday the launch and first implants of its Energen and Punctua cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators in Europe and other markets. They are the world's smallest and thinnest high-energy devices to treat heart failure and sudden cardiac death, according to a company statement. Boston Scientific received CE Mark approval for the devices last October and is hoping for FDA's OK for the devices later this year or early next. Boston Scientific statement

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.